Driscoll Cindy 4
4 · Climb Bio, Inc. · Filed Jan 8, 2026
Insider Transaction Report
Form 4
Climb Bio, Inc.CLYM
Driscoll Cindy
Senior Vice President, Finance
Transactions
- Award
Stock Option (Right to Buy)
2026-01-06+100,000→ 100,000 totalExercise: $3.81Exp: 2036-01-05→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 6, 2026 (the "Grant Date"). The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the Grant Date and the remainder are scheduled to vest in 36 equal monthly installments through January 6, 2030, subject to the Reporting Person's continued service.